Stocklytics Platform
Asset logo for symbol RGLS
Regulus Therapeutics
RGLS58
$7.89arrow_drop_down0.18%-$0.01
Penny Stock
Asset logo for symbol RGLS
RGLS58

$7.89

arrow_drop_down0.18%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Regulus Therapeutics (RGLS) Stocklytics Forecast

According to the latest stock price prediction for Regulus Therapeutics Inc (RGLS), it is expected that the stock price will experience positive growth in the upcoming years. RGLS has shown promising potential in the field of therapeutics, with its innovative approach to RNA-based therapies. The company's strong pipeline and strategic partnerships have positioned it well for future success. Analysts believe that RGLS stock has the potential to outperform the market and reach new heights in the coming years.
Machine learning algorithms have also been used to forecast the future stock price of RGLS. These algorithms analyze a vast amount of data and historical trends to generate predictions with a high degree of accuracy. Based on the machine learning predictions, it is anticipated that RGLS stock will continue to rise steadily in the foreseeable future. This indicates that investing in RGLS stock could be a favorable option for investors looking for long-term growth.
add Regulus Therapeutics  to watchlist

Keep an eye on Regulus Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Regulus Therapeutics (RGLS) stock?

Analysts have set a target price of $8.29 for Regulus Therapeutics (RGLS), based on forecasts from 17 analysts. The predicted price range extends from a high of $12 to a low of $2. This represents a potential increase of up to 51.99% and a decrease of -74.67% from the current price of $7.89. These forecasts are as of 2020 Nov 25.
help

What are the analyst ratings for Regulus Therapeutics (RGLS) stock?

Currently, there are no analyst ratings available for Regulus Therapeutics (RGLS), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Regulus Therapeutics (RGLS) stock?

At present, there is no AI or machine-learning-based price prediction available for Regulus Therapeutics (RGLS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level